Pierre-Olivier Farenq

Pierre-Olivier Farenq is the director of the Centre d’appui des situations à risque at the Agence nationale de sécurité du médicament (ANSM) in France. He has recently been in the news due to the severe supply shortages of quetiapine, a crucial medication for treating bipolar disorder and schizophrenia, which has raised significant concerns among healthcare professionals and patients alike.